Trastuzumab pamirtecan (DB-1303/BNT323) in patients with previously treated HER2-expressing advanced/metastatic endometrial cancer: First global clinical phase 2 data
Bhavana Pothuri, Debra Richardson, Vicky Makker, Whitfield Growdon et autres
3 citationsGynecologic Oncology